Table of Contents
Renal Cell Carcinoma Supplement
| Preface | |
| Fred Saad | S1 |
| Natural History and Management of Small Renal Masses | |
| Simon Tanguay, Tamer Abou Youssif | S2-S7 |
| The Contemporary Role of Surgery in Kidney Cancer | |
| Jean-Baptiste Lattouf, Quoc Diem Trinh, Fred Saad | S8-S15 |
| State of the Art Treatment of Metastatic Renal Cell Carcinoma | |
| Daniel Y C Heng, Christian Kollmannsberger | S16-S23 |
| First-Line Therapy with Sunitinib in Advanced Renal Cell Carcinoma: Interpretation of the Overall Survival Data from ASCO 2008 | |
| Lori Wood | S24-S26 |
| Sorafenib in the Management of Metastatic Renal Cell Carcinoma | |
| Catherine Guevremont, Claudio Jeldres, Pierre I Karakiewicz, Florin I. Mija | S27-S32 |
| mTOR Inhibition in Kidney Cancer | |
| Anil Kapoor | S33-S39 |
| Role of cytokine therapy for Renal Cell Carcinoma in the era of targeted agents | |
| Sebastien J. Hotte, Rama Koneru | S40-S44 |
| Targeted Therapies for Renal Cell Carcinoma – More Gains from Using Them Again | |
| Hui Kong Gan, Bostjan Seruga, Jennifer J Knox | S45-S51 |
| Management of toxicities and optimal dosing of targeted drugs in advanced kidney cancer | |
| Bostjan Seruga, Hui K. Gan, Jennifer J. Knox | S52-S59 |
| Adjuvant and Neoadjuvant Small Molecule Targeted Therapy | |
| Anil Kapoor | S60-S66 |
| Review of guidelines on the treatment of metastatic renal cell carcinoma | |
| Denis Soulieres | S67-S70 |
*Advertisement for Current Oncology
Copyright © 2010 by Multimed Inc.
Current Oncology. ISSN: 1198-0052